Better control and treatment of immune-mediated diseases by exploring the universe of microenvironment imposed tissue signatures and their correlates in liquid biopsies
Site Search
Site Search
Displaying results 361 - 370 of 519
PharmaLedger
European regimen accelerator for tuberculosis
Identifying digital endpoints to assess fatigue, sleep and activities in daily living in neurodegenerative disorders and immune-mediated inflammatory diseases
Immune safety avatar: nonclinical mimicking of the immune system effects of immunomodulatory therapies
Collaboration for prevention and treatment of MDR bacterial infections
EU patient-centric clinical trial platform
26/11/2019
IMI’s EHDEN project dramatically demonstrated the power of using clinical data in research by replicating, during a five-day ‘study-a-thon’, the results of a systematic review...
Identification of the molecular mechanisms of non-response to treatments, relapses and remission in autoimmune, inflammatory, and allergic conditions
Center of excellence – remote decentralised clinical trials
